000 01601 a2200385 4500
005 20250511181818.0
264 0 _c19920415
008 199204s 0 0 eng d
022 _a0022-202X
024 7 _a10.1111/1523-1747.ep12499802
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRosenthal, D S
245 0 0 _aAcute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14.
_h[electronic resource]
260 _bThe Journal of investigative dermatology
_cMar 1992
300 _a343-50 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Topical
650 0 4 _aFilaggrin Proteins
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aIntermediate Filament Proteins
_xanalysis
650 0 4 _aKeratins
_xanalysis
650 0 4 _aMembrane Proteins
_xanalysis
650 0 4 _aProtein Precursors
_xanalysis
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aSkin
_xchemistry
650 0 4 _aTransglutaminases
_xanalysis
650 0 4 _aTretinoin
_xadministration & dosage
700 1 _aGriffiths, C E
700 1 _aYuspa, S H
700 1 _aRoop, D R
700 1 _aVoorhees, J J
773 0 _tThe Journal of investigative dermatology
_gvol. 98
_gno. 3
_gp. 343-50
856 4 0 _uhttps://doi.org/10.1111/1523-1747.ep12499802
_zAvailable from publisher's website
999 _c1378521
_d1378521